Identification of a putative binding site for negatively charged surfaces in the fibronectin type II domain of human factor XII: An immunochemical and homology modeling approach

Thrombosis and Haemostasis

Volumn 84, Issue 6, 2000, Pages 1057-1065

  Citarella, F ^a   Te Velthuis, H ^a   Helmer Citterich, M ^a   Hack, C E ^a  

^a CENTRAL LABORATORY   (Netherlands)

Author keywords

Binding site; Factor XII; Fibronectin type II

Indexed keywords

BLOOD CLOTTING FACTOR 12; DEXTRAN SULFATE; EPITOPE; FIBRONECTIN; KALLIKREIN; KALLIKREIN INHIBITOR; KAOLIN; KOK 5; MONOCLONAL ANTIBODY; PEPTIDE; PEPTIDE LIBRARY; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG INHIBITION; DRUG SCREENING; GENE LIBRARY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; RESIDUE ANALYSIS; SEQUENCE HOMOLOGY; SURFACE CHARGE;

EID: 0034533548     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614171     Document Type: Article

References (56)

1. The biochemistry and pathophysiology of the contact system of plasma
2. Surface-mediated defense reactions. The plasma contact activation system
3. The contact phase of blood coagulation
4. The coagulation? Kinin pathway of human plasma
5. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo
6. Inhibition of factor XII in septic baboons attenuates activation of complement and fibrinolytic system and reduces the release of interleukin-6 and neutrophil elastase
7. Structural biology, cellular interactions and pathophysiology of the contact system
8. Contact system: A vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes
9. Characterization of human blood coagulation Factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa
10. Characterization of the human blood coagulation factor XII gene
11. Factor XII: Hageman factor
12. Human Hageman factor (factor XII0 and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells
13. Assembly of contact-phase factors on the surface of the human neutrophil membrane
14. Activation of Hageman factor in solid and fluid phases
15. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII)
16. Human factor XII (Hageman factor) autoactivation by dextran sulfate circular dichroism, fluorescence, and ultraviolet difference spectroscopic Studies
17. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein
18. Kinetics of activation and autoactivation of human factor XII
19. Initiation of contact system activation in plasma is dependent on factor XII autoactivation and not on enhanced susceptibility of factor XII for kallikrein cleavage
20. A model for the tissue factor pathway to thrombin
21. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen
22. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. Quantification by an enzyme-linked differential antibody immunosorbent assay
23. The contact activation mechanism in human plasma: Activation induced by dextran sulfate
24. Activation of intrinsic blood coagulation by ellagic acid: Insoluble ellagic acid-metal ion complexes are the activating species
25. A monoclonal antibody recognizing an icosapeptide sequence in the heavy chain of human factor XII inhibits surface-catalyzed activation
26. Mapping of a putative surface-binding site of human coagulation factor XII
27. Anticoagulant Property and Conformational Flexibility of factor XII-derived peptides
28. The second exon-encoded factor XII region is involved in the interaction of factor XII with factor XI and does not contribute to the binding site of factor XII for negatively charged surfaces
29. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman Factor)
30. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein
31. Quantification of plasma factor XIIa-C1-Inhibitor and kallikrein-C1-Inhibitor complexes in sepsis
32. Structure/function analysis of human factor XII using recombinant deletion mutants
33. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: Major role for C1-Inhibitor
34. Random peptide libraries: A source of specific protein binding molecules
35. Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector
36. Mimicking of discontinuous epitopes by phage-displayed peptides. I. Epitope mapping of human H ferritin using a phage library of constrained peptides
37. Identification of functional interaction sites on protein using bacteriophage displayed random epitope libraries
38. A sensitive fluorometric assay for quantitatively measuring specific peptide binding to HLA class I and class II molecules
39. Functional characterization of human coagulation factor XIa using hybridoma antibodies
40. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma
41. The regulation of human factor XIIa by plasma proteinase inhibitors
42. Assessment of Hageman factor activation in human plasma: Quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay
43. Detection of activation of the contact system of coagulation in vitro and in vivo: Quantitation of activated Hageman factor-C1-Inhibitor and kallikrein-C1-Inhibitor complexes by specific radioimmunoassays
44. Mechanism of activation of bovine factor XI by factor XII and factor XIIa
45. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunoassorbent assay
46. Sequence-specific 1 H NMR assignments and structural characterization of bovine seminal fluid protein PCD-109 domain b
47. Antigen recognition by conformational selection
48. Characterization of epitopes on human p53 using phage-displayed peptide libraries: Insights into antibody-peptide interactions
49. A priori delineation of a peptide which mimics a discontinuous antigenic determinant
50. Strategies for epitope analysis using peptide synthesis
51. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients
52. Epitopes on protein antigens: Misconceptions and realities
53. Immunochemical characterization of human liver and heart ferritins with monoclonal antibodies
54. Modelling Antibody-Antigen Interactions: Ferritin as a Case Study
55. Histidine residues are essential for the surface binding and autoactivation of human coagulation Factor XII
56. Possible basis for the apparent surface selectivity of the contact activation of human blood coagulation Factor XII